July 2012 - Page 10 of 16

MondayJul 16, 2012 10:21 am

Studio One Media, Inc. (SOMD) Breakthrough Audio and Video Technologies to Transform Entertainment Industry

Studio One Media is a diversified media and technology company. Together with its wholly-owned subsidiaries, which include MyStudio, Inc. and MyStudio Audio Labs, Inc., the company is engaged in the research and development of proprietary, leading-edge audio and video technologies for professional and consumer use. Currently, the company has the ability to generate revenue from three key sources; MyStudio recording sessions, digital advertising and sponsorship opportunities, and mastering or “AfterMastering” of new music as well as existing catalog music. Studio One has extended its presence by establishing strategic partnerships with Simon Cowell's The X Factor, The Grammy Foundation, Mark Burnett…

MondayJul 16, 2012 10:18 am

PolyMedix, Inc. (PYMX) Discusses Potential Benefits from GAIN

Friday, PolyMedix issued a press release that discussed potential benefits the company stands to gain from the passing of the Generating Antibiotics Incentives Now (GAIN) Act into law. The GAIN Act, signed into law last week, will provide incentives for the development of infectious disease products that qualify under the Act, including antibiotics intended to treat drug-resistant pathogens. PolyMedix is a clinical-stage biotechnology company that is focused on developing a new class of antimicrobial agents, known as cidins, for use in the treatment of serious infections. The first of this new class, brilacidin, imitates the mechanism of natural human immunity,…

FridayJul 13, 2012 4:18 pm

RXi Pharmaceuticals Corp. (RXII) Appoints Seasoned Medical Experts to Scientific Advisory Board

Biotech company RXi Pharmaceuticals today announced Dr. Jeannette Graf and Dr. Leroy Young have been added to its Scientific Advisory Board where their experience and research expertise will contribute to the ongoing development of the company’s lead compound. Dr. Graf is a board certified, clinical and research dermatologist with a private practice in Great Neck, NY. She is an assistant clinical professor of Dermatology at the Mount Sinai School of Medicine in New York; an accomplished product developer; and author of best-selling Stop Aging, Start Living. Dr. Graf has made multiple television and news appearances on national news and popular…

FridayJul 13, 2012 1:33 pm

STWA, Inc. (ZERO) Oil Viscosity Reduction Technology Approved for Phase II Field Loop Testing After Successful Lab Testing

STWA continues expanding their portfolio of proprietary applied oil and fuel delivery solutions (developed with and exclusively licensed from Temple University) for the multi-billion dollar oil pipeline and diesel engine markets, reporting today that China's biggest oil producer PetroChina and the China Petroleum Pipeline Administration's (CPP) lab testing of the company's Applied Oil Technology™ (AOT) has generated successful results, leading to approval for Phase II Field Loop Testing. Testing was specifically focused on three of China's most widely produced/consumed oil grades (Daqing, Changqing, and Venezuela crude oil) in order to examine the viscosity reduction capabilities of STWA's AOT technology across…

FridayJul 13, 2012 11:16 am

Misonix, Inc. (MSON) Enters into Three-Year Distribution Agreement with Soelim

Misonix, a surgical device company based in Farmingdale NY, has agreed to a three-year exclusive distribution agreement with Korea-based Soelim Inc., which entitles Soelim the rights to sell and distribute the SonaStar® Ultrasonic Surgical Aspiration System and the BoneScalpel(TM) Ultrasonic Bone Cutting System. The agreement includes details surrounding minimum annual purchase requirements. Included in the deal are the following products and tools: • The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of hard and soft tumors while sparing most vessels and other surrounding tissue. It is engineered to provide powerful and precise ultrasonic aspiration…

FridayJul 13, 2012 10:42 am

Wolverine Exploration, Inc. (WOLV) is “One to Watch”

Incorporated in Nevada on February 23, 2006, Wolverine Exploration is a junior exploration company with headquarters in Vancouver, British Columbia. The company is engaged in the business of the acquisition and exploration of base and precious metal mineral properties, focusing on the exploration of mineral properties in Labrador, Canada. Wolverine Exploration holds a 90 percent interest in 429 mineral claims. These claims cover an area of approximately 10,725 hectares (41 square miles) in central Labrador. The Labrador Claims are located approximately 120 km west of Goose Bay, Labrador. They contain a series of significant copper-gold showings. Concerning infrastructure and build-out,…

FridayJul 13, 2012 10:14 am

ESP Resources, Inc. (ESPI) Video Chart for Friday, July 13, 2012

ESPI could be making a large, double bottom pattern. Support drops as low as $0.077, but the price per share is generally holding above 9 cents at the closing bell each day. Technical traders will be looking for buying pressure as the top-end of the resistance comes in at 15 cents. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayJul 13, 2012 8:32 am

UQM Technologies, Inc. (UQM) PowerPhase® Electric Propulsion System Powers KleenSpeed Electric Race Car to New Record

UQM Technologies, a producer of powerful and efficient electric drive systems for a variety of applications, is excited to congratulate KleenSpeed® Technologies on setting the record for fastest lap at ReFuel 2012. This is the fourth straight year in which the Kleenspeed team has set a new EV lap record at this event. The UQM PowerPhase Select® 145 electric motor and controller system is the power plant for the record-setting KleenSpeed EV-X11 electric racecar. "The KleenSpeed team continues to demonstrate the performance of electric vehicles and advantages of our PowerPhase electric drive systems, providing exceptional power and efficiency with minimal…

FridayJul 13, 2012 8:19 am

Clinical Trials Begin for Zogenix, Inc. (ZGNX) Relday Product Candidate for the Treatment of Schizophrenia

Yesterday, Zogenix announced it has initiated its first IND clinical trial for Relday, a product candidate for treating schizophrenia that is based on a combination of the company’s DosePro needle-free, subcutaneous drug delivery system and a proprietary subcutaneous, once-monthly formulation of risperidone. The Relday phase 1 clinical trial is a single-center, open label, safety and pharmacokinetic trial that will enroll 30 patients with chronic, stable schizophrenia, or schizoaffective disorder. The company anticipates the study results will be available by the end of 2012. Additional study information is available at www.clinicaltrials.gov, reference NCT01592110. Relday represents a significant opportunity for Zogenix to…

ThursdayJul 12, 2012 3:44 pm

Rand Worldwide, Inc. (RWWI) Launches Upgraded EAS Web Access and EAS Entourage Client Tools

Rand Worldwide provides technology solutions to organizations with engineering design and information technology requirements. The company today announced that its Rand Secure Archive division has released two new productivity tools in support of Autonomy's Enterprise Archive Solution (EAS) products. The EAS Web Access Version 2.6 (EWA 2.6) is a Web-based interface that gives end users direct access to archived messages and files without the need for an e-mail client. The EAS Entourage Client Version 3.0.2.3 (EEC 3.0.2.3) is designed for organizations that use Autonomy EAS for Exchange in combination with the Entourage mail client for Mac OS as their e-mail…

Site Search

Company Search

Month: July 2012